...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >The novel phosphoramidate derivatives of NSAID 3-hydroxypropylamides: synthesis, cytostatic and antiviral activity evaluations.
【24h】

The novel phosphoramidate derivatives of NSAID 3-hydroxypropylamides: synthesis, cytostatic and antiviral activity evaluations.

机译:NSAID 3-羟丙基酰胺的新型氨基磷酸酯衍生物:合成,抑制细胞生长和抗病毒活性的评估。

获取原文
获取原文并翻译 | 示例
           

摘要

The target phosphoramidates 5a-e were prepared in one step from 3-hydroxypropyl derivatives 3a-e of nonsteroidal anti-inflammatory drugs (fenoprofen, ketoprofen, ibuprofen, indomethacin, diclofenac). The products 3a-e and 5a-e were evaluated for their cytostatic and antiviral activity against malignant tumour cell lines and normal human fibroblasts (WI 38). All phosphoramidate derivatives 5a-e possess significantly greater inhibitory activities than the corresponding 3-hydroxypropyl derivatives 3a-e, whereby compound 5a showed the most potent inhibitory activities against cervical, pancreatic and colon carcinoma cell lines (IC(50)=5-7 microM).
机译:由非甾体抗炎药(芬诺洛芬,酮洛芬,布洛芬,吲哚美辛,双氯芬酸)的3-羟丙基衍生物3a-e一步制备目标氨基磷酸酯5a-e。评价产物3a-e和5a-e对恶性肿瘤细胞系和正常人成纤维细胞的细胞抑制和抗病毒活性(WI 38)。所有氨基磷酸酯衍生物5a-e具有比相应的3-羟丙基衍生物3a-e更大的抑制活性,因此化合物5a对宫颈,胰腺和结肠癌细胞系表现出最强的抑制活性(IC(50)= 5-7 microM )。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号